Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹542 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,694.0 Cr -4.9% 1.8% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,037.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹170,795.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,332.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹116,933.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,350.2 Cr -4.2% -7% -11.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.9%

1.8%

26.7%

SENSEX

-1.7%

-1.4%

7%


You may also like the below Video Courses